Takeda Pharmaceutical
TAK
#469
Rank
C$71.25 B
Marketcap
C$22.56
Share price
-0.36%
Change (1 day)
6.10%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2025 (TTM): C$4.49 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are C$29.86 Billion. , an increase over its 2024 earnings that were of C$3.03 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2025

Annual earnings

Year Earnings Change
2025 C$4.52 B49.03%
2024 C$3.03 B-2.41%
2023 C$3.11 B-28.14%
2022 C$4.33 B-40.9%
2021 C$7.33 B78.24%
2020 C$4.11 B246.1%
2019 C$1.18 B-48.79%
2018 C$2.32 B-23.64%
2017 C$3.03 B21.7%
2016 C$2.49 B-253.01%
2015 -C$1.64 Billion-159.65%
2014 C$2.73 B13%
2013 C$2.42 B2.46%
2012 C$2.36 B-57.05%
2011 C$5.50 B-10.49%
2010 C$6.14 B-3.99%
2009 C$6.40 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$45.69 B 908.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.27 B 391.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$13.88 B 206.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$12.22 B 169.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.48 B 131.51%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$30.54 B 574.24%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$13.47 B 197.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-C$1.08 Billion-123.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
C$1.18 B-73.74%๐Ÿ‡ฎ๐Ÿ‡ณ India